Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination
| Errataetall: |
CommentOn: J Infect Dis. 2022 Oct 17;226(8):1372-1381. - PMID 35267040 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:226 |
|---|---|
| Enthalten in: |
The Journal of infectious diseases - 226(2022), 8 vom: 17. Okt., Seite 1481-1483 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tjan, Lidya Handayani [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Comment |
|---|
| Anmerkungen: |
Date Completed 18.10.2022 Date Revised 04.12.2022 published: Print CommentOn: J Infect Dis. 2022 Oct 17;226(8):1372-1381. - PMID 35267040 Citation Status MEDLINE |
|---|
| doi: |
10.1093/infdis/jiac159 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340108290 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340108290 | ||
| 003 | DE-627 | ||
| 005 | 20231226004410.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/infdis/jiac159 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1133.xml |
| 035 | |a (DE-627)NLM340108290 | ||
| 035 | |a (NLM)35481958 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tjan, Lidya Handayani |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.10.2022 | ||
| 500 | |a Date Revised 04.12.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: J Infect Dis. 2022 Oct 17;226(8):1372-1381. - PMID 35267040 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a RNA, Messenger |2 NLM | |
| 700 | 1 | |a Furukawa, Koichi |e verfasserin |4 aut | |
| 700 | 1 | |a Kurahashi, Yukiya |e verfasserin |4 aut | |
| 700 | 1 | |a Sutandhio, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Nishimura, Mitsuhiro |e verfasserin |4 aut | |
| 700 | 1 | |a Arii, Jun |e verfasserin |4 aut | |
| 700 | 1 | |a Mori, Yasuko |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infectious diseases |d 1945 |g 226(2022), 8 vom: 17. Okt., Seite 1481-1483 |w (DE-627)NLM000005819 |x 1537-6613 |7 nnns |
| 773 | 1 | 8 | |g volume:226 |g year:2022 |g number:8 |g day:17 |g month:10 |g pages:1481-1483 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/infdis/jiac159 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 226 |j 2022 |e 8 |b 17 |c 10 |h 1481-1483 | ||